News

A new risk stratification model that estimates mortality and risk of appropriate shocks, can identify patients unlikely to benefit from prophylactic implantable cardioverter defibrillator.
Combination treatment with sofosbuvir and simeprevir results in high rates of sustained virologic response in patients with HCV genotype 1 infection and cirrhosis.

Recent improvements in diplomatic relations between the United States and Cuba helped pave the way for Americans to potentially benefit from a promising vaccine that could extend the lives of lung cancer patients and prevent the disease from forming in high-risk individuals. The vaccine, called CimaVax, targets cancerous tumors in the lungs to stop them from growing, according to Dr. Kelvin Lee, chair of the department of immunology at the Roswell Park Cancer Institute in Buffalo, New York. Read More

For the past several years, Express Scripts has been excluding medicines from its coverage list.
A surge of takeover activity involving healthcare, financial and retail companies lifted the value of deals in July over $430 billion.